BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23422484)

  • 21. p27Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells.
    Kudo Y; Takata T; Ogawa I; Kaneda T; Sato S; Takekoshi T; Zhao M; Miyauchi M; Nikai H
    Clin Cancer Res; 2000 Mar; 6(3):916-23. PubMed ID: 10741716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zoledronic acid, a third-generation bisphosphonate, inhibits cellular growth and induces apoptosis in oral carcinoma cell lines.
    Tamura T; Shomori K; Nakabayashi M; Fujii N; Ryoke K; Ito H
    Oncol Rep; 2011 Apr; 25(4):1139-43. PubMed ID: 21249320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mithramycin A inhibits myeloid cell leukemia-1 to induce apoptosis in oral squamous cell carcinomas and tumor xenograft through activation of Bax and oligomerization.
    Shin JA; Jung JY; Ryu MH; Safe S; Cho SD
    Mol Pharmacol; 2013 Jan; 83(1):33-41. PubMed ID: 23019217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-evaluation of tumor-specific cytotoxicity of mitomycin C, bleomycin and peplomycin.
    Sasaki M; Okamura M; Ideo A; Shimada J; Suzuki F; Ishihara M; Kikuchi H; Kanda Y; Kunii S; Sakagami H
    Anticancer Res; 2006; 26(5A):3373-80. PubMed ID: 17094455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of induction chemotherapy efficacy in oral squamous cell carcinoma using pseudotargeted metabolomics.
    Ye G; Liu Y; Yin P; Zeng Z; Huang Q; Kong H; Lu X; Zhong L; Zhang Z; Xu G
    J Proteome Res; 2014 Apr; 13(4):1994-2004. PubMed ID: 24552607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose and glutamine metabolism in oral squamous cell carcinoma: insight from a quantitative metabolomic approach.
    Ogawa T; Washio J; Takahashi T; Echigo S; Takahashi N
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Aug; 118(2):218-25. PubMed ID: 24927638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of tumor-specific cytotoxicity and apoptosis by doxorubicin.
    Suzuki F; Hashimoto K; Kikuchi H; Nishikawa H; Matsumoto H; Shimada J; Kawase M; Sunaga K; Tsuda T; Satoh K; Sakagami H
    Anticancer Res; 2005; 25(2A):887-93. PubMed ID: 15868924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible role of glutathione in mitochondrial apoptosis of human oral squamous cell carcinoma caused by inorganic selenium compounds.
    Takahashi M; Sato T; Shinohara F; Echigo S; Rikiishi H
    Int J Oncol; 2005 Aug; 27(2):489-95. PubMed ID: 16010432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of apoptosis by eugenol in human breast cancer cells.
    Vidhya N; Devaraj SN
    Indian J Exp Biol; 2011 Nov; 49(11):871-8. PubMed ID: 22126019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced susceptibility to apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3-kinase inhibitors.
    Iwase M; Yoshiba S; Uchid M; Takaoka S; Kurihara Y; Ito D; Hatori M; Shintani S
    Int J Oncol; 2007 Nov; 31(5):1141-7. PubMed ID: 17912441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced susceptibility to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in oral squamous cell carcinoma cells treated with phosphatidylinositol 3-kinase inhibitors.
    Uchida M; Iwase M; Takaoka S; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M; Shintani S
    Int J Oncol; 2007 May; 30(5):1163-71. PubMed ID: 17390018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment.
    Ruggieri V; Agriesti F; Scrima R; Laurenzana I; Perrone D; Tataranni T; Mazzoccoli C; Lo Muzio L; Capitanio N; Piccoli C
    Oncotarget; 2015 Jan; 6(2):1217-30. PubMed ID: 25544754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-specific cytotoxicity and type of cell death induced by benzo[b]cyclohept[e][1,4]oxazine and 2-aminotropone derivatives.
    Narita T; Suga A; Kobayashi M; Hashimoto K; Sakagami H; Motohashi N; Kurihara T; Wakabayashi H
    Anticancer Res; 2009 Apr; 29(4):1123-30. PubMed ID: 19414354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type of cell death induced by alpha-trifluoromethyl acyloins in oral squamous cell carcinoma.
    Ideo A; Hashimoto K; Shimada J; Kawase M; Sakagami H
    Anticancer Res; 2009 Jan; 29(1):175-81. PubMed ID: 19331148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Terbinafine inhibits oral squamous cell carcinoma growth through anti-cancer cell proliferation and anti-angiogenesis.
    Chien MH; Lee TS; Kao C; Yang SF; Lee WS
    Mol Carcinog; 2012 May; 51(5):389-99. PubMed ID: 21563217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of antioxidants on radical intensity and cytotoxic activity of eugenol.
    Satoh K; Ida Y; Sakagami H; Tanaka T; Fujisawa S
    Anticancer Res; 1998; 18(3A):1549-52. PubMed ID: 9673369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inositol hexaphosphate and paclitaxel: symbiotic treatment of oral cavity squamous cell carcinoma.
    Janus SC; Weurtz B; Ondrey FG
    Laryngoscope; 2007 Aug; 117(8):1381-8. PubMed ID: 17607147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor effect of novel HSP90 inhibitor NVP-AUY922 against oral squamous cell carcinoma.
    Okui T; Shimo T; Hassan NM; Fukazawa T; Kurio N; Takaoka M; Naomoto Y; Sasaki A
    Anticancer Res; 2011 Apr; 31(4):1197-204. PubMed ID: 21508365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-specificity and type of cell death induced by trihaloacetylazulenes in human tumor cell lines.
    Sekine T; Takahashi J; Nishishiro M; Arai A; Wakabayashi H; Kurihara T; Kobayashi M; Hashimoto K; Kikuchi H; Katayama T; Kanda Y; Kunii S; Motohashi N; Sakagami H
    Anticancer Res; 2007; 27(1A):133-43. PubMed ID: 17352225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.